Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients with hepatocellular carcinoma (HCC). (6th November 2014) - Duffy, Austin; Kerkar, Sid P; Kleiner, David E; Ulahannan, Susanna; Kurtoglu, Metin; Rusher, Oxana; Fioravanti, Suzanne; Walker, Melissa; Figg, William D; Compton, Kathryn; Venkatesan, Aradhana; Abi-Jaoudeh, Nadine; et al.